Get started
Author

Omar Iqbal

Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs
1993 · Lalitha lyer, Michael Koza, et al. · Thrombosis Research · 12
Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using high performance liquid chromatography and functional methods.
1999 · S Ahmad, O Iqbal, et al. · PubMed · 9
Comparative Tissue Factor Pathway Inhibitor Release Potential of Heparins
2005 · M. Tobu, Q. Ma, et al. · Clinical and Applied Thrombosis/Hemostasis · 8
A Perspective on Low Molecular Weight Heparins in the Management of Thrombosis
1993 · Debra Hoppensteadt, Jeanine Walenga, et al. · Hämostaseologie · 5
Increased blood levels of inflammatory cytokines CRP, TNF-α, CD40L, MCP-1 and Nitric Oxide in malignancy-associated thrombosis and their modulation by a low molecular weight heparin, Enoxaparin
2004 · J. Fareed, O. Iqbal, et al. · Journal of Clinical Oncology · 3
Role of PAI-1 and TAFI in the mediation of fibrinolytic deficit in cancer patients
2004 · M. R. Florian-Kujawski, D. Hoppensteadt, et al. · Journal of Clinical Oncology · 3
Current perspectives in antithrombotic therapy
2001 · D. Hoppensteadt, O. Iqbal, et al. · Hämostaseologie · 2
Pharmacokinetics of argatroban in primates: evidence on endogenous uptake.
2000 · S Ahmad, L H Yang, et al. · PubMed · 2
Dosage optimization of antithrombin drugs using ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization and percutaneous coronary interventions
2000 · Omar Iqbal · The Journal of Clinical Pharmacology · 2
Antithrombotics and thrombolytics in stroke.
2002 · Shaker A Mousa, Omar Iqbal, et al. · PubMed · 1
PB0025 Collagen Remodeling, Inflammatory Biomarkers and Fatty Acid Regulation in Understanding the Molecular Pathogenesis of Atrial Fibrillation
2023 · A. Odeh, E. Krupa, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI), Nitric Oxide (NO), and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis
2006 · Debra Hoppensteadt, B Neville, et al. · The FASEB Journal
Molecular Heterogeneity in Recombinant Erythropoietin Using Surface Enhanced Laser Induced Desorption Ionization (SELDI). Clinical Implications.
2005 · E. James, J. Maddineni, et al. · Blood
Comparison of Activated Partial Thromboplastin Time Ratios with Ecarin Clotting Time Ratios for Monitoring Direct Thrombin Inhibitor Therapy: In-Vitro Study and Case Study of Lepirudin Therapy.
2005 · Harry L. Messmore, Nancy J. Fabbrini, et al. · Blood
Potential Role of ADAMTS13/FXI Complexes in the Pathogenesis of End Stage Renal Disease.
2005 · Jawed Fareed, D. Hoppensteadt, et al. · Blood
Heparin-derived oligosaccharides as potential therapeutic agents in senile dementia and stroke
2005 · Q Ma, I Hanin, et al. · CRC Press eBooks
Enhanced Inflammatory response in cancer patients with end stage renal disease. Implications in thrombotic risk stratification
2005 · O. Iqbal, M. Tobu, et al. · Journal of Clinical Oncology
Hyperhomocysteinemia in cancer patients with thrombosis is independent of methylene tetrahydrofolate reductase gene mutation
2004 · M. Tobu, D. A. Hoppensteadt, et al. · Journal of Clinical Oncology
Upregulation of monocyte chemotactic protein-1 and CD40 ligand in cancer patients and their modulation by subcutaneous enoxaparin-results from the ONCENOX study
2004 · O. Iqbal, M. Tobu, et al. · Journal of Clinical Oncology
Fibrinopeptide-A generation inhibition by anti-Xa drugs and its correlation with activated clotting time
2003 · M. Demir, O. Iqbal, et al. · Journal of Thrombosis and Haemostasis
Fibrinolytic and hemodynamic compromise by adjunct therapeutic agents used in thrombolysis. Comparative studies with recombinant tissue factor pathway inhibitor
1994 · D. Hoppensteadt, D. Callas, et al. · Fibrinolysis and Proteolysis
Fibrinolytic compromise by simultaneous administration of synthetic and recombinant antithrombotic agents
1994 · J. Fareed, D. Callas, et al. · Fibrinolysis and Proteolysis
Works count: 22
Citation count: 47
H-index: 4
I10-index: 1
Year
Topic
Type